Maxim Group assumed coverage on shares of Medicus Pharma (NASDAQ:MDCX – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. The firm issued a buy rating and a $10.00 price target on the stock.
Medicus Pharma Stock Performance
NASDAQ:MDCX opened at $2.45 on Tuesday. Medicus Pharma has a 1-year low of $1.80 and a 1-year high of $6.00.
About Medicus Pharma
Recommended Stories
- Five stocks we like better than Medicus Pharma
- What Are Dividends? Buy the Best Dividend Stocks
- Micron Stock Under $100: Seize the AI-Driven Upside
- What is the Hang Seng index?
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Why is the Ex-Dividend Date Significant to Investors?
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
-oil--gas-ltd-logo-1200x675.png?v=20221229143825&h=45&w=95&zc=2){kind=logo}
